PSYC Primed for Launch During Covid-19
April 21 2020 - 8:30AM
InvestorsHub NewsWire
Las Vegas, NV -- April 21, 2020 --
InvestorsHub NewsWire -- Global Trac Solutions, Inc. (OTCPink:
PSYC) (“Global” “PSYC” or the “Company”) is pleased to announce
they have engaged with a variety of key industry experts in an
effort to plan and prepare for the Company’s intended initial
launch set for May 2020. Such efforts have included identifying and
establishing strategic partnerships with various individuals and
companies whom PSYC will look to collaborate with over the next
several weeks and months. The Company will be working on
collaborations in the areas of media, website and brand strategy as
it positions itself for what it anticipates to be a very effective
launch into the emerging business sector of psychedelic
medicine.
“In recent weeks we have witnessed
our world and our daily lives change significantly as a result of
the ongoing COVID-19 pandemic. We have also seen a steady increase
in studies and overall focus surrounding a variety of alternative
medicines and treatments, including those associated with
psychedelics based on the possible benefits for treating anxiety,
depression, PTSD, and more. Most recently Rolling Stone Magazine
published an interesting article surrounding Swiss chemist Albert
Hoffmann’s psychedelic discovery, and in it they state,
‘More recently, Silicon Valley
billionaires have been examining the profitability of the
industry, neuro-pharmaceutical corporations are developing
commercial psychedelic compounds, and the Wall Street
Journal is covering psychedelic startups.’ We were
fortunate to watch the cannabis industry grow into a sustainable
marketplace for both medicinal and recreational use. Part of that
journey surrounded research and development including working
alongside industry experts to gain the knowledge and understanding
needed to service that industry. We will be embarking on the same
path for psychedelic medicine by engaging with industry experts,
which will likely expand to a new advisory board and a more defined
approach, which will result in a unique plan to engage this
market,” said Vanessa Luna, CEO of PSYC.
PSYC is at the forefront of
psychedelic medicine, we will work with several ancillary
businesses to provide a network of resources for our current
subscribers, while expanding that network to those pioneers
advocating for change and legislation within this
arena.
Cited
Sources:
https://www.rollingstone.com/culture/culture-news/bicycle-day-albert-hofmann-lsd-psychedelic-986279/
About Global Trac
Solutions, Inc. (OTC
Pink:PSYC)
Global Trac
Solutions is a diversified holding company dedicated to identifying
new and emerging industries. By utilizing our years of business
development expertise our diverse team of innovators continuously
leverages our experience to effectively execute go-to-market
strategies in order to position ourselves for rapid growth through
the creation of an evolving business foundation to enhance
profitability potential.
Since 2017, PSYC has
been a pioneer in the emerging software and payment processing
sector of the cannabis industry and has established itself as a
trusted resource for businesses operating within the industry.
Today, PSYC through its network of partners and affiliates,
continues to connect businesses throughout the cannabis industry
with critical solutions and services ranging from payment
processing technology, cutting-edge software, and ancillary
services vital to compliant and effective business
operations.
Most recently, PSYC
has expressed its intent and commitment to positioning itself at
the forefront of the psychedelic revolution and as a resource
center for discovering and understanding the latest research and
business opportunities surrounding psychedelic inspired medicines.
In conjunction with the FDA’s more open-minded approach to
psychedelic medicines, and as several major U.S. cities continue to
approve the decriminalization of psilocybin, investors are
speculating that the psychedelic boom could be bigger than that of
cannabis. PSYC is your source for current investment related news
specific to psychedelic medicines and cutting-edge research
improving overall health, moving this sector into the
mainstream.
We believe in a
forward-thinking approach that embraces groundbreaking new
technology and innovations and through the vision of business
development we intend to continue to evolve into these unchartered
territories as the industry leaders of the future. We truly are the
right TRAC to follow.
Forward-Looking
Statements Disclaimer:
This
press release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended.
In some cases, you can identify forward-looking statements by the
following words: "anticipate," "believe," "continue," "could,"
"estimate," "expect," "intend," "may," "ongoing," "plan,"
"potential," "predict," "project," "should," "will," "would," or
the negative of these terms or other comparable terminology,
although not all forward-looking statements contain these words.
Forward-looking statements are not a guarantee of future
performance or results and will not necessarily be accurate
indications of the times at, or by, which such performance or
results will be achieved. Forward-looking statements are based on
information available at the time the statements are made and
involve known and unknown risks, uncertainty and other factors that
may cause our results, levels of activity, performance or
achievements to be materially different from the information
expressed or implied by the forward-looking statements in this
press release. This press release should be considered in light of
all filings of the Company that are disclosed on the OTC
Markets.com website.
Corporate
Contact:
Global Trac Solutions,
Inc. (PSYC)
www.globaltracsolutions.com
(619)
925-3202
info@globaltracsolutions.com
PSYC (PK) (USOTC:PSYC)
Historical Stock Chart
From Mar 2024 to Apr 2024
PSYC (PK) (USOTC:PSYC)
Historical Stock Chart
From Apr 2023 to Apr 2024